Efflux pump inhibitors to reduce duration of antituberculosis therapy
$2,355,000DP2FY2007ODNIH
Ut Southwestern Medical Center, Dallas TX
Investigators
Linked publications, trials & patents
Paper 30694692Paper 30496465Paper 30496464Paper 29844047Paper 28922805Paper 28696238Paper 27216055Paper 27211555Paper 26926650Paper 25645834Paper 25645830Paper 25248645Paper 25092691Paper 24580808Paper 24041886Paper 23183434Paper 22820329Paper 22751536Paper 21807559Paper 20937778Paper 20439617Paper 20210628Paper 20086150Paper 19451303
View original record on NIH RePORTER →